Brainomix’s e-Lung shows progression and treatment response in Phase III trial
Brainomix has debuted data from a Phase III progressive pulmonary fibrosis (PPF) study that highlights the ability of its AI-powered…
News
EASD 2026: Regeneron’s muscle preserver shows benefit at lower doses
Zealand dips on Boehringer-paired obesity drug’s Phase III result
Cyclo goes forth with Niemann-Pick drug’s approval bid despite Phase III miss
EASD 2026: Lilly’s amylin-tirzepatide combo beats its weight loss drug alone
R1 Therapeutics secures $80.5m to fund Phase IIb AP306 study
MSD’s Phase IIb study of tulisokibart achieves primary endpoint
Invivyd’s Covid-directed mAb hits Phase III safety goals
